BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16340839)

  • 21. Pulmonary preneoplasia--sequential molecular carcinogenetic events.
    Lantuéjoul S; Salameire D; Salon C; Brambilla E
    Histopathology; 2009 Jan; 54(1):43-54. PubMed ID: 19187179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reliability of cytologic diagnosis of early lung cancer.
    Vazquez MF; Koizumi JH; Henschke CI; Yankelevitz DF
    Cancer; 2007 Aug; 111(4):252-8. PubMed ID: 17614298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor receptor mutation in lung cancer are linked to bronchioloalveolar differentiation.
    Blons H; Côté JF; Le Corre D; Riquet M; Fabre-Guilevin E; Laurent-Puig P; Danel C
    Am J Surg Pathol; 2006 Oct; 30(10):1309-15. PubMed ID: 17001163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EGFR assays in lung cancer.
    Dacic S
    Adv Anat Pathol; 2008 Jul; 15(4):241-7. PubMed ID: 18580100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung.
    Kim YT; Kim TY; Lee DS; Park SJ; Park JY; Seo SJ; Choi HS; Kang HJ; Hahn S; Kang CH; Sung SW; Kim JH
    Lung Cancer; 2008 Jan; 59(1):111-8. PubMed ID: 17904685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new era for bronchioloalveolar carcinoma: current state of the art and recent advances in biologically targeted therapy.
    Johal BS; Laskin J
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1411-9. PubMed ID: 17069526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lung cancer--epidemiology, prognosis and therapy].
    Martini B
    Med Monatsschr Pharm; 2006 Jun; 29(6):217-21. PubMed ID: 16792198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant mesothelioma masquerading as a multinodular bronchioloalveolar cell adenocarcinoma with widespread pulmonary nodules.
    Felner KJ; Wieczorek R; Kline M; Smith RL; Sidhu GS
    Int J Surg Pathol; 2006 Jul; 14(3):229-33. PubMed ID: 16959710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between morphology and EGFR mutations in lung adenocarcinomas Significance of the micropapillary pattern and the hobnail cell type.
    Ninomiya H; Hiramatsu M; Inamura K; Nomura K; Okui M; Miyoshi T; Okumura S; Satoh Y; Nakagawa K; Nishio M; Horai T; Miyata S; Tsuchiya E; Fukayama M; Ishikawa Y
    Lung Cancer; 2009 Feb; 63(2):235-40. PubMed ID: 18571764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffuse consolidation form of bronchoalveolar carcinoma.
    Khalil KF; Saeed W; Zill-e-Hamayun
    J Coll Physicians Surg Pak; 2010 Mar; 20(3):216-8. PubMed ID: 20392391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection sensitivity of a commercial lung nodule CAD system in a series of pathologically proven lung cancers.
    Godoy MC; Cooperberg PL; Maizlin ZV; Yuan R; McWilliams A; Lam S; Mayo JR
    J Thorac Imaging; 2008 Feb; 23(1):1-6. PubMed ID: 18347512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The place of targeted therapies in the management of non-small cell bronchial carcinoma. Molecular markers as predictors of tumor response and survival in lung cancer.
    Rosell R; Moran T; Fernanda Salazar M; Mendez P; De Aguirre I; Ramirez JL; Isla D; Cobo M; Camps C; Lopez-Vivanco G; Alberola V; Taron M
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S131-16S136. PubMed ID: 17268350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing multifocal bronchioloalveolar carcinoma/lepidic predominant adenocarcinoma: changing rules for an evolving clinical entity.
    West HJ
    Clin Adv Hematol Oncol; 2014 Sep; 12(9):593-600. PubMed ID: 25654480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytologic differential diagnosis of various peripheral lung cancers].
    Kharchenko VP; Galil-Ogly GA; Bershchanskaia AM; Iarovaia NIu; Mel'nikova NV; Paklina OV
    Vopr Onkol; 2002; 48(2):229-31. PubMed ID: 12227075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pulmonary scintigraphy and bronchial cancer].
    Lamy P; Martin J; Anthoine D; Rebeix G; Vaillant D; Vaillant G
    Poumon Coeur; 1967; 23(3):295-302. PubMed ID: 6076953
    [No Abstract]   [Full Text] [Related]  

  • 37. [The exfoliative cytology of bronchiolo-alveolar cancer].
    Djelali D
    Ann Otolaryngol Chir Cervicofac; 1969 Jun; 86(6):338-9. PubMed ID: 5821328
    [No Abstract]   [Full Text] [Related]  

  • 38. [Bronchiolo-alveolar carcinoma (apropos of 7 cases)].
    Zitouna M; Kaabar A; Thameur H; Boubaker S; Fodha M; Robbana M; Hafsia M
    Tunis Med; 1983; 61(2):123-7. PubMed ID: 6680952
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnostic and therapeutic failures in bronchopulmonary carcinoma].
    Krstić S
    Tuberkuloza; 1965; 17(1):117-25. PubMed ID: 5828078
    [No Abstract]   [Full Text] [Related]  

  • 40. [Broncho-pulmonary cancer: what's new? The clinician's point of view].
    Lebeau B
    Ann Pathol; 1993; 13(6):368-71. PubMed ID: 8141929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.